{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:15:47Z","timestamp":1787984147717,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"novartis pharmaceuticals australia pty ltd","award":["."],"award-info":[{"award-number":["."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Sleep disturbance and fatigue are commonly reported in ankylosing spondylitis (AS) but specific prevalence and the relationship to disease control are unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>This retrospective non-interventional observational study of data from the OPAL dataset included patients with AS (ICD code M45, M45.0 or M08.1), aged 18 to 95\u00a0years and had completed\u2009\u2265\u20091 sleep questionnaire between 1 January 2019 and 30 September 2020. The prevalence of insomnia and obstructive sleep apnoea were assessed using the Insomnia Severity Index (ISI) and Multivariate Apnoea Prediction Index (MAPI), respectively. Propensity score (PS) matching based on sex, age and symptom duration increased comparability between patients administered tumour necrosis factor inhibitors (TNFi) and interleukin 17A inhibitors (IL-17Ai).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Four hundred ninety-five patients were included. The mean ISI total score in the overall population was 8.6\u2009\u00b1\u20096.2. Self-reported moderate or severe clinical insomnia was present in 16% and 3.2% of patients, respectively. The mean MAPI score was 0.4\u2009\u00b1\u20090.3, self-reported apnoea was identified in 31.5% of patients and the mean FACIT-Fatigue score was 36.1\u2009\u00b1\u200910.7. In the PS matched population, the only treatment-related difference was the mean MAPI score (IL-17Ai 0.4\u2009\u00b1\u20090.3 and TNFi 0.3\u2009\u00b1\u20090.2, <jats:italic>p<\/jats:italic>\u2009=\u20090.046). Those with poor disease control (BASDAI\u2009\u2265\u20094) were more likely (odds ratio [OR] 7.29, 95% CI 2.37 to 22.46, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) to have a greater severity of insomnia symptoms than those with good disease control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this real-world AS cohort, poor disease control was associated with sleep disturbance. Little difference in sleep disturbance was observed between biologic TNFi and IL-17Ai treatment.<\/jats:p>\n                <jats:p><jats:table-wrap><jats:table><jats:tbody>\n                      <jats:tr>\n                        <jats:td align=\"left\"><jats:bold>Key Points<\/jats:bold><\/jats:td>\n                      <\/jats:tr>\n                      <jats:tr>\n                        <jats:td align=\"left\"><jats:italic>\u2022 Sleep disturbance and fatigue are common in patients with ankylosing spondylitis.<\/jats:italic><jats:italic>\u2022 In our real-world cohort, self-reported apnoea was reported in one-third of patients; and one in five patients reported moderate to severe insomnia.<\/jats:italic><jats:italic>\u2022 Those with poor disease control were more likely to experience greater sleep disturbance than those with good disease control.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                    <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10067-021-05953-8","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T06:01:22Z","timestamp":1637906482000},"page":"1105-1114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prevalence of sleep disturbance and the association between poor disease control in people with ankylosing spondylitis within the Australian clinical setting (ASLEEP study): a real-world observational study using the OPAL dataset"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-8105","authenticated-orcid":false,"given":"Kathleen","family":"Tymms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1415-4065","authenticated-orcid":false,"given":"Belinda E.","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-7838","authenticated-orcid":false,"given":"Tracey L.","family":"Sletten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-9712","authenticated-orcid":false,"given":"Tegan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0564-9768","authenticated-orcid":false,"given":"Catherine","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7896-055X","authenticated-orcid":false,"given":"Geoffrey","family":"Littlejohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Tronnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5869-797X","authenticated-orcid":false,"given":"Hedley","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the OPAL consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"issue":"8","key":"5953_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/13548506.2019.1574357","volume":"24","author":"Z Li","year":"2019","unstructured":"Li Z, Fu T, Wang Y, Dong C, Shao X, Li L, Gu Z (2019) Sleep disturbances in ankylosing spondylitis: a systematic review and meta-analysis. Psychol Health Med 24(8):911\u2013924. https:\/\/doi.org\/10.1080\/13548506.2019.1574357","journal-title":"Psychol Health Med"},{"issue":"8","key":"5953_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11926-014-0434-7","volume":"16","author":"C Mercieca","year":"2014","unstructured":"Mercieca C, van der Horst-Bruinsma IE, Borg AA (2014) Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice. Curr Rheumatol Rep 16(8):434. https:\/\/doi.org\/10.1007\/s11926-014-0434-7","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"5953_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejr.2012.02.001","volume":"34","author":"O Abdulaziez","year":"2012","unstructured":"Abdulaziez O, Asaad T (2012) Sleep problems in ankylosing spondylitis: polysomnographic pattern and disease related variables. Egypt Rheumatol 34(2):59\u201365. https:\/\/doi.org\/10.1016\/j.ejr.2012.02.001","journal-title":"Egypt Rheumatol"},{"issue":"5","key":"5953_CR4","doi-asserted-by":"publisher","first-page":"R215","DOI":"10.1186\/ar4054","volume":"14","author":"Y Li","year":"2012","unstructured":"Li Y, Zhang S, Zhu J, Du X, Huang F (2012) Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study. Arthritis Res Ther 14(5):R215. https:\/\/doi.org\/10.1186\/ar4054","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"5953_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.rbr.2014.12.007","volume":"55","author":"E Aydin","year":"2015","unstructured":"Aydin E, Bayraktar K, Turan Y, Omurlu I, Tastaban E, Sendur OF (2015) Sleep quality in patients with ankylosing spondylitis. Rev Bras Reumatol 55(4):340\u2013345. https:\/\/doi.org\/10.1016\/j.rbr.2014.12.007","journal-title":"Rev Bras Reumatol"},{"issue":"4","key":"5953_CR6","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1111\/jcmm.14170","volume":"23","author":"H Fang","year":"2019","unstructured":"Fang H, Tu S, Sheng J, Shao A (2019) Depression in sleep disturbance: a review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med 23(4):2324\u20132332. https:\/\/doi.org\/10.1111\/jcmm.14170","journal-title":"J Cell Mol Med"},{"issue":"32","key":"5953_CR7","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.2174\/138161208786549281","volume":"14","author":"JM Krueger","year":"2008","unstructured":"Krueger JM (2008) The role of cytokines in sleep regulation. Curr Pharm Des 14(32):3408\u20133416. https:\/\/doi.org\/10.2174\/138161208786549281","journal-title":"Curr Pharm Des"},{"issue":"3","key":"5953_CR8","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3892\/etm.2018.7110","volume":"17","author":"H Ming","year":"2019","unstructured":"Ming H, Tian A, Liu B, Hu Y, Liu C, Chen R, Cheng L (2019) Inflammatory cytokines tumor necrosis factor-alpha, interleukin-8 and sleep monitoring in patients with obstructive sleep apnea syndrome. Exp Ther Med 17(3):1766\u20131770. https:\/\/doi.org\/10.3892\/etm.2018.7110","journal-title":"Exp Ther Med"},{"issue":"4","key":"5953_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1183\/09031936.00007008","volume":"32","author":"MA Arias","year":"2008","unstructured":"Arias MA, Garcia-Rio F, Alonso-Fernandez A, Hernanz A, Hidalgo R, Martinez-Mateo V, Bartolome S, Rodriguez-Padial L (2008) CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 32(4):1009\u20131015. https:\/\/doi.org\/10.1183\/09031936.00007008","journal-title":"Eur Respir J"},{"issue":"6","key":"5953_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.5664\/jcsm.2254","volume":"8","author":"JA Walsh","year":"2012","unstructured":"Walsh JA, Duffin KC, Crim J, Clegg DO (2012) Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors. J Clin Sleep Med 8(6):643\u2013648. https:\/\/doi.org\/10.5664\/jcsm.2254","journal-title":"J Clin Sleep Med"},{"key":"5953_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1445-5994.2010.02466.x","volume":"41","author":"L Roberts","year":"2011","unstructured":"Roberts L, Arnold M, Bird P, Burnet S, De Jager J, Littlejohn G, Nicholls D, Tymms K, Zochling J, Griffiths H (2011) ARA-P39 optimising patient outcomes in Australian rheumatology (OPAL) - a quality use of medicines initiative (QUMI) with >7000 rheumatoid arthritis (RA) patients. Intern Med J 41:9\u201338. https:\/\/doi.org\/10.1111\/j.1445-5994.2010.02466.x","journal-title":"Intern Med J"},{"issue":"5","key":"5953_CR12","first-page":"874","volume":"38","author":"GO Littlejohn","year":"2020","unstructured":"Littlejohn GO, Tymms KE, Smith T, Griffiths HT (2020) Using big data from real-world Australian rheumatology encounters to enhance clinical care and research. Clin Exp Rheumatol 38(5):874\u2013880","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5953_CR13","first-page":"487","volume":"23","author":"SD Jones","year":"1996","unstructured":"Jones SD, Koh WH, Steiner A, Garrett SL, Calin A (1996) Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 23(3):487\u2013490","journal-title":"J Rheumatol"},{"issue":"3","key":"5953_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46(3):399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786","journal-title":"Multivariate Behav Res"},{"key":"5953_CR15","doi-asserted-by":"publisher","unstructured":"Shahid A, Wilkinson K, Marcu S, Shapiro CM (2011) Insomnia severity index (ISI). In: Shahid A (ed) STOP, THAT and one hundred other sleep scales. pp 191\u2013193. https:\/\/doi.org\/10.1007\/978-1-4419-9893-4_43","DOI":"10.1007\/978-1-4419-9893-4_43"},{"issue":"6","key":"5953_CR16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","volume":"43","author":"J Brandt","year":"2000","unstructured":"Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, Thriene W, Sieper J, Braun J (2000) Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 43(6):1346\u20131352. https:\/\/doi.org\/10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","journal-title":"Arthritis Rheum"},{"issue":"3","key":"5953_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/sleep\/18.3.158","volume":"18","author":"G Maislin","year":"1995","unstructured":"Maislin G, Pack AI, Kribbs NB, Smith PL, Schwartz AR, Kline LR, Schwab RJ, Dinges DF (1995) A survey screen for prediction of apnea. Sleep 18(3):158\u2013166. https:\/\/doi.org\/10.1093\/sleep\/18.3.158","journal-title":"Sleep"},{"key":"5953_CR18","unstructured":"Adams R, Appleton S, Taylor A, Mcevoy D, Antic N (2016) Report to the Sleep Health Foundation. 2016 sleep health survey of Australian adults"},{"issue":"1","key":"5953_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.sleh.2016.11.005","volume":"3","author":"RJ Adams","year":"2017","unstructured":"Adams RJ, Appleton SL, Taylor AW, Gill TK, Lang C, McEvoy RD, Antic NA (2017) Sleep health of Australian adults in 2016: results of the 2016 Sleep Health Foundation national survey. Sleep Health 3(1):35\u201342. https:\/\/doi.org\/10.1016\/j.sleh.2016.11.005","journal-title":"Sleep Health"},{"key":"5953_CR20","unstructured":"Tymms K (2019) Impact of sleep disturbance in ankylosing spondylitis. Research Reviews"},{"issue":"19","key":"5953_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020055","volume":"99","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lin S, Li C, Shi Y, Guan W (2020) Sleep apnea-hypopnea syndrome caused by ankylosing spondylitis: a case report. Medicine (Baltimore) 99(19):e20055. https:\/\/doi.org\/10.1097\/MD.0000000000020055","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"5953_CR22","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00296-011-1907-x","volume":"32","author":"O Karadag","year":"2012","unstructured":"Karadag O, Nakas D, Kalyoncu U, Akdogan A, Kiraz S, Ertenli I (2012) Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol Int 32(7):1909\u20131913. https:\/\/doi.org\/10.1007\/s00296-011-1907-x","journal-title":"Rheumatol Int"},{"issue":"6","key":"5953_CR23","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/1756-185X.13102","volume":"21","author":"G Karatas","year":"2018","unstructured":"Karatas G, Bal A, Yuceege M, Firat H, Gurcay E, Ardic S, Cakci FA (2018) Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-alpha therapy on sleep problems: a polisomnographic study. Int J Rheum Dis 21(6):1263\u20131269. https:\/\/doi.org\/10.1111\/1756-185X.13102","journal-title":"Int J Rheum Dis"},{"key":"5953_CR24","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1471-2466-14-84","volume":"14","author":"L Ying","year":"2014","unstructured":"Ying L, Li H, Pan Z, Ma S, Zhang P, Wang Q, Lu G, Zhou J (2014) Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea\/hypopnoea syndrome (OSAHS). BMC Pulm Med 14:84. https:\/\/doi.org\/10.1186\/1471-2466-14-84","journal-title":"BMC Pulm Med"},{"key":"5953_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-6632.2001.tb05826.x","volume":"933","author":"JM Krueger","year":"2001","unstructured":"Krueger JM, Obal FJ, Fang J, Kubota T, Taishi P (2001) The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 933:211\u2013221. https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb05826.x","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"5953_CR26","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3906\/sag-1605-62","volume":"47","author":"S Yolbas","year":"2017","unstructured":"Yolbas S, Yildirim A, Duzenci D, Gundogdu B, Ozgen M, Koca SS (2017) Sleep quality, sleeping postures, and sleeping equipment in patients with ankylosing spondylitis. Turk J Med Sci 47(4):1198\u20131205. https:\/\/doi.org\/10.3906\/sag-1605-62","journal-title":"Turk J Med Sci"},{"issue":"2","key":"5953_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","volume":"20","author":"AK McDonough","year":"2008","unstructured":"McDonough AK, Curtis JR, Saag KG (2008) The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20(2):131\u2013137. https:\/\/doi.org\/10.1097\/BOR.0b013e3282f51031","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"5953_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/smrv.2002.0260","volume":"7","author":"AS Jordan","year":"2003","unstructured":"Jordan AS, McEvoy RD (2003) Gender differences in sleep apnea: epidemiology, clinical presentation and pathogenic mechanisms. Sleep Med Rev 7(5):377\u2013389. https:\/\/doi.org\/10.1053\/smrv.2002.0260","journal-title":"Sleep Med Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05953-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05953-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05953-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T16:39:18Z","timestamp":1647016758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05953-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5953"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05953-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"assertion":[{"value":"8 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by University of New South Wales (UNSW) Human Research Ethics Committee (HREC) (HC180712).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The activities of OPAL Rheumatology Ltd have received overarching ethics approval from the UNSW HREC, based on a patient opt-out arrangement (HC17799). This research protocol was approved by the UNSW HREC (HC180712).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"KT, TLS, GL and HG report no conflicts of interest. RT and RS are employees of Novartis Pharmaceuticals Australia Pty Ltd. TS and CO are employees of OPAL Rheumatology Ltd. BEB is an independent statistician who was contracted by OPAL Rheumatology Ltd to perform the analysis. OPAL independently developed the study design, protocol, statistical analysis plan and data analysis. We do invite the appropriate medical employee or real-world evidence team member from the sponsoring company to give input and review of the final manuscript. The decision to publish the results from this study was not dependent on the results obtained nor influenced by the sponsoring company and interpretation of the data remains with the rheumatologist\/principal investigator on the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}}]}}